InvestorsObserver
×
News Home

Bellicum Pharmaceuticals Inc (BLCM) Stock Loses -16.11% This Week; Should You Buy?

Thursday, March 04, 2021 12:19 PM | InvestorsObserver Analysts

Mentioned in this article

Bellicum Pharmaceuticals Inc (BLCM) Stock Loses -16.11% This Week; Should You Buy?

Bellicum Pharmaceuticals Inc (BLCM) stock has fallen -57.67% over the last 12 months, and the average rating from Wall Street analysts is a Hold. InvestorsObserver’s proprietary ranking system, gives BLCM stock a score of 18 out of a possible 100.

That rank is primarily influenced by a short-term technical score of 1. BLCM's rank also includes a long-term technical score of 1. The fundamental score for BLCM is 53. In addition to the average rating from Wall Street analysts, BLCM stock has a mean target price of 4.5. This means analysts expect the stock to increase 20.00% over the next 12 months.

Overall Score - 18
BLCM has an Overall Score of 18. Find out what this means to you and get the rest of the rankings on BLCM!

What's Happening with BLCM Stock Today

Bellicum Pharmaceuticals Inc (BLCM) stock is trading at $3.75 as of 12:15 PM on Thursday, Mar 4, a decline of -$0.10, or -2.6% from the previous closing price of $3.85. The stock has traded between $3.75 and $4.45 so far today. Volume today is 917,734 compared to average volume of 1,217,952.

Click Here to get the full Stock Score Report on Bellicum Pharmaceuticals Inc (BLCM) Stock.

You May Also Like

Get the InvestorsObserver App

InvestorsObserver App
iOS App Android App